Overview
Status
Active
Registry date
2010-05-19
Share capital
200,000.00 PLN
Registered address
Krasickiego 2 A/46, 81-385 Gdynia, Poland
Financials
Revenue history
Filing timeliness
1 of 6 financial statements not filed.
- 202528/03/2026
- 202421/02/2025
- 202321/04/2024
- 202227/05/2023
- 2021not filed
- 202022/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Cezary Leszek Matusewicz – Attorney-in-fact (sole)
Renata Firgon – President of the Management Board
Manner of representation
Each member of the management board is independently entitled to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Renata Firgonage 63 | 800 | $21,609.94 | 40% |
Daria Lucyna Świderskaage 37 | 1,199 | $32,387.90 | 59.95% |
Others | 1 | $27.01 | 0.05% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2008-11-30.
85 1020 4649 0000 7602 0321 5720
Debt
No entries in the National Debtors Register (KRZ).
Public aid
7 public aid cases recorded, with a total value of $232,194.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 1, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,510$1,510 | Ośrodek Doradztwa I Treningu Kierowniczego | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,383$1,383 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,383$1,383 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-03-01 | Internationalisation of the business of Best – Life Biotechnology Sp. z o.o. in new promising foreign markets | $225K$224,989 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nitorasp. z o.o. | $1,601,259.44 | nitoralab.com | ||
| Farmacia Verdesp. z o.o. + limited partnership | $898,115.71 | farmaciaverde.pl | ||
| Farmacia Verdesp. z o.o. | $41,891.92 | farmaciaverde.pl | ||
| Kovalitesp. z o.o. | $21,161.45 | kovalite.com | ||
| Innoplexsp. z o.o. | $11,707.96 | innoplex.global | ||
| Nucadeasp. z o.o. | $297.62 | nucadea.com | ||
| Herbiopharmsp. z o.o. | $0.00 | herbiopharm.pl | ||
| MCS Laboratorysp. z o.o. | $0.00 | mcslaboratory.com | ||
| Loton Cosmeticssp. z o.o. | – | loton.pl | ||
| Luminalabsp. z o.o. | – | bioclinical.us |
Change history
| Date | Event | |
|---|---|---|
| 2020-12-17 | PKD change (Removed: 26 codes; Added: 1 code) | |
| 2012-05-07 | Name change ("best-Life" → "best-Life Biotechnology") | |
| 2010-05-19 | Entered in the register |
FAQ
The main business activity of Best-Life Biotechnology focuses on manufacture of perfumes and toilet preparations.
The company was registered in the Polish National Court Register (KRS) on May 19, 2010.
The headquarters is located at: Krasickiego 2 A, 81-385 Gdynia.
The share capital of the company is PLN 200,000 (approx. $54,025).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-03-28